| Mr Joseph C Law, PHARMACIST | |
|
11860 Calle Cielo, Gilroy, CA 95020-9435 | |
| (510) 248-7577 | |
| Not Available |
| Full Name | Mr Joseph C Law |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 11860 Calle Cielo, Gilroy, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073692323 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 30032 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Joseph C Law, PHARMACIST 11860 Calle Cielo, Gilroy, CA 95020 Ph: (510) 248-7577 | Mr Joseph C Law, PHARMACIST 11860 Calle Cielo, Gilroy, CA 95020-9435 Ph: (510) 248-7577 |
News Archive
Harden Healthcare, a Texas-based senior healthcare services provider with operations in 14 states, announced today that its subsidiary, Hospice Care of Kansas, will change its name to Harden Hospice Kansas effective immediately.
In the largest study of its kind to date, researchers have used DNA sequencing to uncover dozens of genes that heighten the risk for autism. Joseph Buxbaum, Ph.D., Icahn School of Medicine at Mount Sinai, New York City, Mark Daly, Ph.D., Broad Institute of Harvard and MIT, and their colleagues examined more than 14,000 DNA samples from affected children, parents and unrelated people.
CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."
In a large randomized study, the immunotherapy drug nivolumab, a checkpoint inhibitor, was shown to be a safe and effective therapy for kidney cancer even in patients who continued treatment after their disease progressed.
LGBT Health, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers, launching in fall 2013, presents a timely and in-depth perspective on several key controversies surrounding gender diagnoses.
› Verified 2 days ago
Walter Specht, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 1st St, Gilroy, CA 95020 Phone: 408-847-6777 Fax: 408-846-9439 | |
Tiffany Herrgott, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 1st St, Gilroy, CA 95020 Phone: 408-842-0373 | |
Serena Wei-jung Pu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7251 Camino Arroyo, Gilroy, CA 95020 Phone: 408-842-0702 | |
Tilma Kozean Wright, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 1st St, Gilroy, CA 95020 Phone: 408-847-6777 Fax: 408-846-9439 | |
Cosette Yu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 1st St, Gilroy, CA 95020 Phone: 408-842-0373 | |
Akram Kildani, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7475 Edinburg Wy, Gilroy, CA 95020 Phone: 408-644-9708 |